Endocrine Society Argues for Inclusion of EDCs in EU Chemicals Strategy

In May, the European Commission released a roadmap outlining plans for a Chemicals Strategy for Sustainability. The Chemicals Strategy, which will form a component of the European Green Deal, seeks to “reduce the risks associated with producing and using chemicals” by improving the European Union (EU) regulatory process and strengthening the regulatory framework for harmful chemicals.

The Endocrine Society’s EU Endocrine-Disrupting Chemicals (EDC) Task Force submitted comments to the Roadmap to ensure that the Chemicals Strategy advances our priorities and improves EU regulation of chemicals that interfere with endocrine systems. Our members stressed the need for ambitious legislative measures to address common EDC exposures that are consistent with the latest endocrine science. We also called for the identification of gaps in testing strategies and an accelerated and more coherent identification process for EDCs.

As policy makers develop and revise the Chemicals Strategy and other components of the EU Green Deal, the Endocrine Society will continue to ensure that EDCs are prioritized due to the ongoing harm that they cause to humans and the environment.

For the latest news on EDCs in the EU, we encourage members to check out our new online newsletter on the Endocrine Society’s EDC webpage at endocrine.org/edc.

 

You may also like

  • Endocrine Society Advocacy Update – March 2024

    Endocrine Society Advocates to Protect and Increase Funding for the NIH  On March 5, the Endocrine Society will conduct a Researcher Hill Day to advocate for the importance of the National Institutes of Health (NIH). We are asking Congress to complete work on a funding bill for the remainder of fiscal year (FY) 2024, before…

  • Advocacy Update: February 2024

    Federal Funding for SDP, NIH in Jeopardy As the February issue of Endocrine News went to press, the government had only days to fund the Special Diabetes Program (SDP) and the National Institutes of Health (NIH) before funding expired.  It was expected that Congress would pass another short-term funding bill that would fund these programs…